CEO of the Multiple Myeloma Research Foundation makes the TIME 100 list

Friday, April 22, 2011 12:19 PM

TIME has named Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation (MMRF), to the 2011 TIME 100, the magazine’s annual list of the 100 most influential people in the world.

Guisti was selected for the TIME 100 list for the progress she has made in the way medical research and drug development are conducted and improving the outlook for patients with multiple myeloma, a deadly form of blood cancer, as well as other cancers.

In 2004, Kathy founded the MMRF’s affiliate organization, MMRC to focus on conducting phase I and phase II clinical trials of novel compounds. To date, the MMRC has launched 30 clinical trials of new and combination therapies 60% faster than the industry standard, including eight now in late stage clinical development.

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs